Community Based Rehabilitation After Knee Arthroplasty
CORKA
COmmunity Based Rehabilitation After Knee Arthroplasty (CORKA): A Prospective Two Arm Individually Randomised Controlled Trial
1 other identifier
interventional
621
0 countries
N/A
Brief Summary
Background The CORKA study was developed in response to a commissioned call by the National Institute for Health Research (NIHR) Health Technology Assessment (HTA) programme for research into a functional home based rehabilitation programme for patients who may be at risk of poor outcome after knee arthroplasty. Design The CORKA trial is a prospective individually randomised controlled trial with blinded outcome assessment at baseline, 6 and 12 months. The study will also include a qualitative and a health economic analysis. Participants will be randomised to one of two arms, 'home-based rehabilitation' or 'Usual Care'. Those in the usual care arm will receive a minimum of 1 and a maximum of 6 sessions of physiotherapy as delivered locally, e.g. class, one to one, etc. Those in the intervention arm will receive 7 sessions of a functional rehabilitation programme over a 12 week timescale. The intervention will be delivered using physiotherapists and physiotherapy assistants in the participants' home. Participants will be followed up at 6 months and 12 months
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2015
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 17, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 26, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2018
CompletedFirst Submitted
Initial submission to the registry
April 27, 2021
CompletedFirst Posted
Study publicly available on registry
April 30, 2021
CompletedApril 30, 2021
April 1, 2021
2.9 years
April 27, 2021
April 29, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
To compare the patient reported functional outcome and quality of life of the CORKA trial rehabilitation protocol versus standard care in participants at risk of poor outcome after knee replacement
functional outcome LLFDI
over 12 months
Secondary Outcomes (3)
To assess the safety and serious adverse events associated with the treatment programme: SAE
over 12 months
To assess the acceptability to the treatment programme for patients and therapists through both a RCT and a nested qualitative study
over 12 months
To assess the cost effectiveness of the different treatment strategies
over 12 months
Study Arms (2)
Usual Care
OTHERParticipants will receive the care that would usually be received in the local hospital setting. this has been determined as between 1 and 6 sessions of physiotherapy
Intervention
EXPERIMENTALParticipants will receive a home based rehabilitation programme with 1-7 sessions of physiotherapy delivered over 12 weeks.
Interventions
Eligibility Criteria
You may qualify if:
- Participant is willing and able to give informed consent for participation in the study Male or Female, aged 55 years or above Primary unilateral KR as a scheduled procedure Deemed by study screening tool developed to be at risk of poor outcome Happy to allow physiotherapy teams to attend their home to deliver the Community based rehabilitation programme if randomised to the intervention arm.
You may not qualify if:
- Any absolute contraindications to exercise Severe cardiovascular or pulmonary disease (New York Heart Association III-IV) Severe dementia, assessed using the hospital dementia screening tool Rheumatoid arthritis Further lower limb arthroplasty surgery planned within 12 months. Serious perioperative complications
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Oxfordlead
- HTAcollaborator
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 27, 2021
First Posted
April 30, 2021
Study Start
March 17, 2015
Primary Completion
January 26, 2018
Study Completion
March 30, 2018
Last Updated
April 30, 2021
Record last verified: 2021-04